Showing results (31-40 of 326) with videos related to
Sort By:
Pageof 33
Neuro-Oncology|September 6, 2008
New (alternative) temozolomide regimens for the treatment of gliomaWolfgang Wick, Michael Platten, Michael WellerOncoimmunology|June 28, 2012
The aryl hydrocarbon receptor in tumor immunityMichael Platten, Ulrike Litzenburger, Wolfgang WickNeuro-Oncology Advances|November 5, 2021
Comparative evaluation of T-cell receptors in experimental glioma-draining lymph nodesJens Blobner, Michael Kilian, Chin Leng Tan, et al.The Lancet. Oncology|December 8, 2016
Neurological sequelae of cancer immunotherapies and targeted therapiesWolfgang Wick, Anne Hertenstein, Michael PlattenCNS Oncology|July 24, 2014
Shaping the glioma immune microenvironment through tryptophan metabolismMichael Platten, Michael Weller, Wolfgang WickCancers|January 13, 2021
A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human TumorsBarbara Costa, Michael N C Fletcher, Pavle Boskovic, et al.Neurological Research and Practice|May 22, 2022
AMPLIFY-NEOVAC: a randomized, 3-arm multicenter phase I trial to assess safety, tolerability and immunogenicity of IDH1-vac combined with an immune checkpoint inhibitor targeting programmed death-ligand 1 in isocitrate dehydrogenase 1 mutant gliomasLukas Bunse, Anne-Kathleen Rupp, Isabel Poschke, et al.Current Opinion in Neurology|October 5, 2011
Geriatric neuro-oncology: from mythology to biologyMichael Weller, Michael Platten, Patrick Roth, et al.Der Nervenarzt|May 16, 2019
[Treatment-associated neurological symptoms of cancer patients and their treatment]Iris Mildenberger, Philipp Eisele, Ralf Hofheinz, et al.Health Promotion International|November 21, 2024
Can health impact assessment help tackle commercial determinants of health and support a wellbeing economy?Margaret J Douglas, Catherine Foster, Rosalind McDermott, et al.Pageof 33